Full Text View
Tabular View
No Study Results Posted
Related Studies
Warfarin and Antiplatelet Therapy in Chronic Heart Failure
This study has been completed.
Study NCT00007683   Information provided by Department of Veterans Affairs
First Received: December 29, 2000   Last Updated: January 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
Aspirin
Clopidogrel
Additional drug interventions recognized in this trial
Warfarin
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Department of Veterans Affairs
Canadian Regional Coordinating Ctr
UK Regional Coordinating Ctr
Economic Analysis Lab &Echo Core Lab
Sanofi-Synthelabo
Bristol-Myers Squibb
Dupont Applied Biosciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services